- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 17/02 - Peptides immobilisés sur, ou dans, un support organique
Détention brevets de la classe C07K 17/02
Brevets de cette classe: 386
Historique des publications depuis 10 ans
|
19
|
28
|
26
|
21
|
26
|
30
|
19
|
17
|
19
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Ith Immune Therapy Holdings | 15 |
9 |
| The Regents of the University of California | 20669 |
8 |
| Finncure Oy | 13 |
7 |
| Lawrence Livermore National Security, LLC | 1972 |
6 |
| Immunwork Inc. | 26 |
4 |
| L.e.a.f. Holdings Group LLC | 122 |
4 |
| MedImmune Limited | 610 |
4 |
| Elicio Therapeutics Inc. | 31 |
4 |
| Centre National de La Recherche Scientifique | 10976 |
3 |
| Board of Regents, The University of Texas System | 6077 |
3 |
| Kaneka Corporation | 4684 |
3 |
| Animal Allergy Clinical Laboratories Inc. | 15 |
3 |
| The Brigham and Women's Hospital, Inc. | 2282 |
3 |
| Cornell University | 3412 |
3 |
| The Council of the Queensland Institute of Medical Research | 164 |
3 |
| Denka Company Limited | 2708 |
3 |
| Leukocare AG | 42 |
3 |
| National University Corporation Kyoto Institute of Technology | 208 |
3 |
| Nippon Zenyaku Kogyo Co., Ltd. | 57 |
3 |
| Riken | 1716 |
3 |
| Autres propriétaires | 304 |